» Authors » C Bruns

C Bruns

Explore the profile of C Bruns including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 151
Citations 2186
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmanton-Garcia J, Bruns C, Rutz J, Albertsmeier M, Ankert J, Bernard L, et al.
J Hosp Infect . 2024 Mar; 147:123-132. PMID: 38467251
Background: Surgical site infections (SSIs), mainly caused by Staphylococcus aureus, pose a significant economic burden in Europe, leading to increased hospitalization duration, mortality, and treatment costs, particularly with drug-resistant strains...
2.
Bernarding J, Bruns C, Prediger I, Mutzel M, Plaumann M
Sci Rep . 2024 Jan; 14(1):1527. PMID: 38233411
In biological tissues, F magnetic resonance (MR) enables the non-invasive, background-free detection of F-containing biomarkers. However, the signal-to-noise ratio (SNR) is usually low because biomarkers are typically present at low...
3.
Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, et al.
Ann Oncol . 2023 Sep; 34(11):1015-1024. PMID: 37657554
Background: The optimal time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer is unknown and has traditionally been 4-6 weeks in clinical practice. Observational studies have suggested better...
4.
Eckhoff J, Ban Y, Rosman G, Muller D, Hashimoto D, Witkowski E, et al.
Surg Endosc . 2023 Mar; 37(5):4040-4053. PMID: 36932188
Background: Surgical phase recognition using computer vision presents an essential requirement for artificial intelligence-assisted analysis of surgical workflow. Its performance is heavily dependent on large amounts of annotated video data,...
5.
Seufferlein T, Uhl W, Kornmann M, Algul H, Friess H, Konig A, et al.
Ann Oncol . 2022 Oct; 34(1):91-100. PMID: 36209981
Background: Data on perioperative chemotherapy in resectable pancreatic ductal adenocarcinoma (rPDAC) are limited. NEONAX examined perioperative or adjuvant chemotherapy with gemcitabine plus nab-paclitaxel in rPDAC (National Comprehensive Cancer Network criteria)....
6.
Schoemmel M, Loeser H, Kraemer M, Wagener-Ryczek S, Hillmer A, Bruns C, et al.
Clin Transl Oncol . 2021 Feb; 23(8):1601-1610. PMID: 33566304
Introduction: The inflammatory microenvironment has emerged as one of the focuses of cancer research. Little is known about the immune environment in esophageal adenocarcinoma (EAC) and possible tumor-escape mechanisms to...
7.
Quaas A, Schloesser H, Fuchs H, Zander T, Arolt C, Scheel A, et al.
Ann Surg Oncol . 2020 Dec; 28(7):3975-3982. PMID: 33305335
Background: In esophageal carcinoma, the numbers of metastatic and total removed lymph nodes (LN) are well-established variables of long-term prognosis. The overall rate of retrieved LN depends on neoadjuvant treatment,...
8.
Konradsson M, van Berge Henegouwen M, Bruns C, Chaudry M, Cheong E, Cuesta M, et al.
Dis Esophagus . 2019 Oct; 33(4). PMID: 31608938
Delayed gastric conduit emptying (DGCE) after esophagectomy for cancer is associated with adverse outcomes and troubling symptoms. Widely accepted diagnostic criteria and a symptom grading tool for DGCE are missing....
9.
Filmann N, Walter D, Schadde E, Bruns C, Keck T, Lang H, et al.
Br J Surg . 2019 Jul; 106(11):1523-1529. PMID: 31339558
Background: Mortality rates after liver surgery are not well documented in Germany. More than 1000 hospitals offer liver resection, but there is no central regulation of infrastructure requirements or outcome...
10.
Colpoys J, Van Sambeek D, Bruns C, Johnson A, Dekkers J, Dunshea F, et al.
Domest Anim Endocrinol . 2019 Feb; 68:32-38. PMID: 30784946
Increasing the feed efficiency of lean tissue gains is an important goal for improving sustainable pork production and profitability for swine producers. To study feed efficiency, genetic selection based on...